Pricing Log in Create free account

Galecto, Inc. (DMRA) vs Structure Therapeutics Inc. Sponsored ADR (GPCR)

Galecto, Inc. and Structure Therapeutics Inc. Sponsored ADR are both Biotechnology companies. Galecto, Inc. and Structure Therapeutics Inc. Sponsored ADR are of similar size ($1.4B and $1.4B). Structure Therapeutics Inc. Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Galecto, Inc. trades at 24.7×. Across the 9 metrics below, Structure Therapeutics Inc. Sponsored ADR leads on 5 and Galecto, Inc. on 4.

Valuation

Metric DMRA GPCR Biotechnology median
P/E 24.65 n/m 10.60
P/S n/m n/m 9.40
P/B 4.00 1.09 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield 4.06% (15.31%) (32.88%)
Free cash flow yield (4.05%) (15.20%) (23.13%)

Profitability

Metric DMRA GPCR Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (39.51%) (20.21%) (51.96%)
Return on assets (27.08%) (19.17%) (46.06%)
Return on invested capital 0.00% (1,371.78%) 0.00%

Growth

Metric DMRA GPCR Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (730.84%) (2.47%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DMRA GPCR Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 14.80 20.75 4.97
Net debt to EBITDA 1.22 8.27 1.01

Dividend

Metric DMRA GPCR Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric DMRA GPCR Biotechnology median
Market cap 1.35b 1.36b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack